Clinical outcome of hypertension management

References

• Ezzati M, Lopez AD, Rodgers A, et al. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–1360
   PubMed Web of Science ®Google Scholar
• Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223
   PubMed Web of Science ®Google Scholar
• Chan NN, Tong PCY, Chan JCN. Management of systemic hypertension: an update for primary care physicians. The Hong Kong Practitioner 2005; 27: 4–14
   Google Scholar
• He J, Klag MJ, Wu Z, et al. Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. Stroke 1995; 26: 2228–2232
   PubMed Web of Science ®Google Scholar
• Blood pressure, cholesterol, and stroke in Eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet 1998; 352: 1801–1807
   Google Scholar
• Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 Summary. Advance Data National Ambulatory Medical Care Survey: 2000 Summary 2002; 328: 1–32
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252
   PubMed Web of Science ®Google Scholar
• Population Health Survey 2003/2004. Collaborative Project of Department of Health and Department of Community Medicine, University of Hong Kong, 2005: i–ii. Available from: http://www.chp.gov.hk/files/pdf/full_report_on_population_health_survey_2003_2004_en_20051024.pdf [last assessed 22 August 2007]
   Google Scholar
• Cheung BM, Law FC, Lau CP. The rule of halves applies in Chinese hypertensive patients. American Journal of Hypertension 2002; 15: 209A
   Google Scholar
• Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 356: 1955–1964
   PubMed Web of Science ®Google Scholar
• Hodgson TA, Cai L. Medical care expenditures for hypertension, its complications, and its comorbidities. Medical Care 2001; 39: 599–615
   PubMed Web of Science ®Google Scholar
• Lee VWY, Chan WK, Lam NLC, et al. Cost of acute myocardial infarction in Hong Kong. Disease Management & Health Outcomes 2005; 13: 281–285
   Google Scholar
• 1999 World Health Organization–International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. Journal of Hypertension 1999; 17: 151–183
   PubMed Web of Science ®Google Scholar
• Arauz-Pacheco C, Parrott MA, Raskin P. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003; 26((Suppl 1))S80–S82
   Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 2002; 39((2 Suppl 1))S1–S266
   PubMed Web of Science ®Google Scholar
• Kannel WB. Hypertensive risk assessment: cardiovascular risk factors and hypertension. Journal of Clinical Hypertension 2004; 6: 393–399
   PubMedGoogle Scholar
• Prince of Wales Hospital Drug Formulary, 2006
   Google Scholar
• List of Charges. Hong Kong Government Gazette, Special Supplement No. 4 (13), 2003
   Google Scholar
• Liddell FDK. Simplified exact analysis of case-referent studies: matched pairs; dichotomous exposure. Journal of Epidemiology and Community Health 1983; 37: 82–84
   PubMed Web of Science ®Google Scholar
• Hong Kong in Figures, 2007 Edition. Census and Statistics Department, Government of the Hong Kong Special Administrative Region. Available from: http://www.censtatd.gov.hk/FileManager/EN/Common/hkinf.pdf [last assessed 22 August 2007]
   Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group; The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of the American Medical Association 2002; 288: 2981–2997, [Errata. JAMA 2003; 289: 178; JAMA 2004; 291: 2196.]
   PubMed Web of Science ®Google Scholar
• Wing LM, Reid CM, Ryan P, et al. Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. New England Journal of Medicine 2003; 348: 583–592
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Sever PS, Poulter NR, et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT–BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895–906
   PubMed Web of Science ®Google Scholar
• Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 White men. Multiple Risk Factor Intervention Trial Research Group. Archives of Internal Medicine 1992; 152: 56–64
   PubMed Web of Science ®Google Scholar
• O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990; 15: 339–347
   PubMed Web of Science ®Google Scholar
• Izzo Jr JL, Levy D, Black HR, Clinical Advisory Statement: importance of systolic blood pressure in older Americans. National Heart Lung and Blood Institute, 2001. Available from: http://www.nhlbi.nih.gov/health/prof/heart/ hbp/hbpstmt/index.htm [last assessed 22 August 2007]
   Google Scholar
• Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. American Journal of Cardiology 1971; 27: 335–345
   PubMed Web of Science ®Google Scholar
• Black HR, Elliott WJ, Neaton JD, et al. Baseline characteristics and early blood pressure control in the CONVINCE trial. Hypertension 2001; 37: 12–18
   PubMed Web of Science ®Google Scholar